Large-scale testing (Phase 3)WithdrawnNCT04546802What this trial is testingHepATocellular Cancer Hcv Therapy StudyWho this might be right forHepatocellular CarcinomaHepatomaLiver Cell Carcinoma+1 more Bayside Health
Large-scale testing (Phase 3)Ended earlyNCT00003056What this trial is testingPrevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaGraft Versus Host Disease Baxalta now part of Shire 105
Testing effectiveness (Phase 2)Study completedNCT02775903What this trial is testingAn Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)Who this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Celgene 213
Large-scale testing (Phase 3)Study completedNCT01321541What this trial is testingComparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell TransplantWho this might be right forDiffuse Large B-cell Lymphomade Novo DLBCLDLBCL Transformed From Indolent Lymphoma+1 more CTI BioPharma 312
Testing effectiveness (Phase 2)Looking for participantsNCT04240054What this trial is testingBortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal InsufficiencyWho this might be right forMultiple Myeloma Medical College of Wisconsin 41
Testing effectiveness (Phase 2)UnknownNCT02445404What this trial is testingCompare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCLWho this might be right forPeripheral T-cell Lymphoma Samsung Medical Center 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802356What this trial is testingBelantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma PatientsWho this might be right forMultiple Myeloma PETHEMA Foundation 50
Large-scale testing (Phase 3)Looking for participantsNCT06932562What this trial is testingLearn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for TransplantWho this might be right forMultiple Myeloma European Myeloma Network B.V. 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT02390869What this trial is testingRituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL PatientsWho this might be right forLymphoma, Follicular Fondazione Italiana Linfomi - ETS 128
Early research (Phase 1)Study completedNCT03790072What this trial is testingEx-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML)Who this might be right forAcute Myeloid Leukemia TC Biopharm 10
Testing effectiveness (Phase 2)WithdrawnNCT03608501What this trial is testingIxazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell TransplantationWho this might be right forMultiple Myeloma Takeda
Testing effectiveness (Phase 2)UnknownNCT03669445What this trial is testingStudy Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple MyelomaWho this might be right forMultiple Myeloma University Hospital, Toulouse 45
Large-scale testing (Phase 3)Looking for participantsNCT06879379What this trial is testingKPD Consolidation After ASCT in NDMM PatientsWho this might be right forMultiple Myeloma, Newly Diagnosed Peking University People's Hospital 202
Testing effectiveness (Phase 2)Study completedNCT01562977What this trial is testingStudy to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCLWho this might be right forAggressive LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 82
Not applicableStudy completedNCT04649801What this trial is testingCatheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart TransplantationWho this might be right forHeart FailureAtrial Fibrillation Heart and Diabetes Center North-Rhine Westfalia 194
Testing effectiveness (Phase 2)Study completedNCT03961919What this trial is testingPhase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic TransplantWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesTransplant-Related Hematologic Malignancy Ciceri Fabio 15
Testing effectiveness (Phase 2)Study completedNCT02686346What this trial is testingBrentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICEWho this might be right forHodgkin Disease The Lymphoma Academic Research Organisation 53
Not applicableNot Yet RecruitingNCT07746232What this trial is testingValidating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"Who this might be right forMultiple Myeloma (MM) Fondazione EMN Italy Onlus 92
Large-scale testing (Phase 3)UnknownNCT00934557What this trial is testingRandomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell TransplantationWho this might be right forPaediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer Fondazione IRCCS Policlinico San Matteo di Pavia 42
Testing effectiveness (Phase 2)Looking for participantsNCT06793449What this trial is testingBCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Institute of Hematology & Blood Diseases Hospital, China 80